Show simple item record

dc.contributor.authorFox, Christopher
dc.contributor.authorAhearne, Matthew
dc.date.accessioned2022-03-11T15:33:28Z
dc.date.available2022-03-11T15:33:28Z
dc.date.issued2022
dc.identifier.citationFox, C. P., Ahearne, M. J., Pettengell, R., Dearden, C., El-Sharkawi, D., Kassam, S., Cook, L., Cwynarski, K., Illidge, T., & Collins, G. (2022). Guidelines for the management of mature T- and natural killer-cell lymphomas (excluding cutaneous T-cell lymphoma): a British Society for Haematology Guideline. British journal of haematology, 196(3), 507–522. https://doi.org/10.1111/bjh.17951en_US
dc.identifier.other10.1111/bjh.17951
dc.identifier.urihttp://hdl.handle.net/20.500.12904/15247
dc.description.abstractMethodology This guideline was developed according to the British Society for Haematology (BSH) process at http://www.b-s-h.org.uk/guidelines. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) nomenclature was used to evaluate levels of evidence and to assess the strength of recommendations. The GRADE criteria are described at http://www.gradeworkinggroup.org. Literature review details Ovid MEDLINE and PubMed were searched for English language articles up to December 2020 using the keywords: peripheral T-cell lymphoma, T prolymphocytic leukaemia, large granular lymphocyte leukaemia, adult T-cell leukaemia lymphoma, anaplastic large cell lymphoma, peripheral T-cell lymphoma not otherwise specified, angioimmunoblastic T-cell lymphoma, extra-nodal natural killer (NK)/T-cell lymphoma, aggressive NK cell leukaemia, enteropathy associated T-cell lymphoma, monomorphic epitheliotropic intestinal T-cell lymphoma, hepatosplenic T-cell lymphoma. Review of the manuscript Review of the manuscript was performed by the BSH Guidelines Committee, Haematology Oncology Task Force and the members of Haematology Oncology sounding board of the BSH. It was also on the members section of the BSH website for comment.
dc.description.urihttps://onlinelibrary.wiley.com/doi/10.1111/bjh.17951en_US
dc.subjectT-cell lymphomaen_US
dc.subjectguidelineen_US
dc.subjectlymphoid malignanciesen_US
dc.titleGuidelines for the management of mature T- and natural killer-cell lymphomas (excluding cutaneous T-cell lymphoma): a British Society for Haematology Guidelineen_US
dc.typeArticleen_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
rioxxterms.versionNAen_US
rioxxterms.versionofrecordhttps://doi.org/10.1111/bjh.17951en_US
rioxxterms.typeJournal Article/Reviewen_US
refterms.panelUnspecifieden_US
refterms.dateFirstOnline2022
html.description.abstractMethodology This guideline was developed according to the British Society for Haematology (BSH) process at http://www.b-s-h.org.uk/guidelines. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) nomenclature was used to evaluate levels of evidence and to assess the strength of recommendations. The GRADE criteria are described at http://www.gradeworkinggroup.org. Literature review details Ovid MEDLINE and PubMed were searched for English language articles up to December 2020 using the keywords: peripheral T-cell lymphoma, T prolymphocytic leukaemia, large granular lymphocyte leukaemia, adult T-cell leukaemia lymphoma, anaplastic large cell lymphoma, peripheral T-cell lymphoma not otherwise specified, angioimmunoblastic T-cell lymphoma, extra-nodal natural killer (NK)/T-cell lymphoma, aggressive NK cell leukaemia, enteropathy associated T-cell lymphoma, monomorphic epitheliotropic intestinal T-cell lymphoma, hepatosplenic T-cell lymphoma. Review of the manuscript Review of the manuscript was performed by the BSH Guidelines Committee, Haematology Oncology Task Force and the members of Haematology Oncology sounding board of the BSH. It was also on the members section of the BSH website for comment.en_US
rioxxterms.funder.project94a427429a5bcfef7dd04c33360d80cden_US


This item appears in the following Collection(s)

Show simple item record